海尔生物
(688139)
| 流通市值：97.23亿 | | | 总市值：97.23亿 |
| 流通股本：3.18亿 | | | 总股本：3.18亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 831,055,160.95 | 901,227,075.69 | 983,791,234.62 | 1,151,899,865.06 |
| 应收票据及应收账款 | 444,649,434.93 | 330,991,696.12 | 447,310,936.31 | 393,451,647.22 |
| 其中：应收票据 | 12,751,992.99 | 7,145,875.33 | 7,350,475.79 | 1,708,273.56 |
| 应收账款 | 431,897,441.94 | 323,845,820.79 | 439,960,460.52 | 391,743,373.66 |
| 应收款项融资 | 14,862,320.15 | 12,418,141.22 | 446,407.8 | 9,989,221.36 |
| 预付款项 | 20,042,685.06 | 27,267,096.16 | 19,950,887.63 | 19,290,706.62 |
| 其他应收款合计 | 7,810,091.81 | 8,556,956.91 | 8,234,663.14 | 9,301,742.7 |
| 存货 | 303,739,515.42 | 334,744,974.95 | 258,026,061.32 | 244,993,394.53 |
| 合同资产 | 9,200,569.81 | 9,348,923.99 | 5,205,741.83 | 1,789,666.34 |
| 一年内到期的非流动资产 | 327,082,511.02 | 126,539,483.63 | 51,825,683.8 | 151,235,412.36 |
| 其他流动资产 | 10,062,997.81 | 24,103,642.14 | 19,853,470.35 | 21,158,796.47 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 2,863,421,109.96 | 2,652,447,941.35 | 2,660,812,428.8 | 2,405,604,989.66 |
| 非流动资产: | | | | |
| 长期股权投资 | 183,880,063.55 | 137,987,031.94 | 134,806,348.12 | 133,181,471.47 |
| 其他权益工具投资 | 41,397,596.47 | 41,397,596.47 | 28,199,861.65 | 28,199,861.65 |
| 其他非流动金融资产 | 9,000,000 | 9,000,000 | 9,000,000 | 9,000,000 |
| 投资性房地产 | 8,660,741.25 | 8,857,663.47 | 9,045,063.75 | 9,241,985.97 |
| 固定资产 | 791,880,590.41 | 807,291,286.02 | 802,356,927.99 | 810,585,608.69 |
| 在建工程 | 101,101,731.5 | 95,034,029.25 | 96,950,701.65 | 77,351,106.94 |
| 使用权资产 | 11,548,025.67 | 12,854,331.79 | 14,016,749.21 | 12,539,069.54 |
| 无形资产 | 392,870,662.41 | 402,302,641.03 | 413,962,989.63 | 425,371,371.98 |
| 商誉 | 758,097,771.67 | 757,866,205.38 | 758,169,731.51 | 757,755,028.67 |
| 长期待摊费用 | 6,331,467.5 | 6,715,706 | 6,516,454.13 | 6,713,900.47 |
| 递延所得税资产 | 66,673,482.55 | 66,008,575.05 | 62,490,424.74 | 62,592,740.56 |
| 其他非流动资产 | 595,577,358.5 | 789,705,787.26 | 645,367,055.64 | 848,584,539.19 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 2,967,019,491.48 | 3,135,020,853.66 | 2,980,882,308.02 | 3,181,116,685.13 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 5,830,440,601.44 | 5,787,468,795.01 | 5,641,694,736.82 | 5,586,721,674.79 |
| 流动负债: | | | | |
| 短期借款 | 10,007,777.78 | 10,009,027.78 | 19,096,331.82 | 21,104,670.4 |
| 应付票据及应付账款 | 466,777,643.97 | 427,598,354.67 | 434,231,479.44 | 423,326,041.66 |
| 其中：应付票据 | 105,880,065.91 | 90,192,201.48 | 102,814,580.99 | 110,535,492.82 |
| 应付账款 | 360,897,578.06 | 337,406,153.19 | 331,416,898.45 | 312,790,548.84 |
| 合同负债 | 85,129,205.55 | 151,984,833.74 | 61,621,731.09 | 55,794,947.72 |
| 应付职工薪酬 | 66,785,937.39 | 83,940,305.47 | 82,845,494.45 | 73,356,340.12 |
| 应交税费 | 51,878,400.37 | 50,913,525.45 | 51,236,833.51 | 51,768,970.32 |
| 其他应付款合计 | 262,472,171.51 | 273,354,626.83 | 276,454,629.34 | 289,181,966.93 |
| 一年内到期的非流动负债 | 13,126,023.03 | 13,204,768.63 | 17,396,747.19 | 15,954,925.15 |
| 其他流动负债 | 10,729,877.37 | 11,398,099.94 | 5,958,435.7 | 6,144,161.86 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 966,907,036.97 | 1,022,403,542.51 | 948,841,682.54 | 936,632,024.16 |
| 非流动负债: | | | | |
| 长期借款 | 10,007,222.22 | - | - | - |
| 租赁负债 | 7,018,616.98 | 7,432,212.61 | 8,766,942.32 | 7,597,964.98 |
| 长期应付款 | 55,929,429.32 | 55,252,585.16 | 54,607,357.16 | 53,962,129.16 |
| 预计负债 | 8,560,784.75 | 8,560,784.75 | 5,596,795.14 | 5,596,795.14 |
| 递延收益 | 22,352,884.62 | 23,168,795.89 | 27,328,207.18 | 28,536,368.41 |
| 递延所得税负债 | 50,863,349.83 | 52,514,841.3 | 55,078,023.9 | 56,829,367.66 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 154,732,287.72 | 146,929,219.71 | 151,377,325.7 | 152,522,625.35 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 1,121,639,324.69 | 1,169,332,762.22 | 1,100,219,008.24 | 1,089,154,649.51 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 317,952,508 | 317,952,508 | 317,952,508 | 317,952,508 |
| 资本公积 | 1,978,331,416.73 | 1,977,335,357.14 | 1,975,507,012.43 | 1,989,000,700.16 |
| 减:库存股 | 167,204,433.14 | 140,197,717.52 | 140,197,717.52 | 125,409,937.49 |
| 其他综合收益 | -2,236,031.38 | -2,693,310.15 | -13,291,752.57 | -14,079,617.69 |
| 盈余公积 | 158,976,254 | 158,976,254 | 158,976,254 | 158,976,254 |
| 未分配利润 | 2,170,435,659.89 | 2,060,177,419.54 | 2,002,686,468.81 | 1,927,887,457.5 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 4,456,255,374.1 | 4,371,550,511.01 | 4,301,632,773.15 | 4,254,327,364.48 |
| 少数股东权益 | 252,545,902.65 | 246,585,521.78 | 239,842,955.43 | 243,239,660.8 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 4,708,801,276.75 | 4,618,136,032.79 | 4,541,475,728.58 | 4,497,567,025.28 |
| 负债和股东权益合计 | 5,830,440,601.44 | 5,787,468,795.01 | 5,641,694,736.82 | 5,586,721,674.79 |
| 公告日期 | 2025-04-30 | 2025-03-29 | 2024-10-30 | 2024-08-23 |
| 审计意见(境内) | | 标准无保留意见 | | |